Muscular dystrophies Trials in Columbus, United States
Conditions / Muscular dystrophies / Columbus, United States
Muscular dystrophies is a medical condition with active clinical research programs worldwide.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01826487 | Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) | COMPLETED | PHASE3 |
| NCT07287189 | Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients | RECRUITING | — |
| NCT03981289 | Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) | COMPLETED | — |
| NCT01462292 | A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD) | COMPLETED | PHASE2 |
| NCT05257473 | Defining Endpoints in Becker Muscular Dystrophy | ACTIVE_NOT_RECRUITING | — |
| NCT05479981 | Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients | COMPLETED | PHASE2 |
| NCT05747924 | Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) | COMPLETED | — |
| NCT02090959 | An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy | TERMINATED | PHASE3 |
| NCT01803412 | A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects | TERMINATED | PHASE3 |
| NCT06547216 | Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD) | ENROLLING_BY_INVITATION | PHASE2 |